Supernus Announces Third Quarter 2015 Financial Results and Raises 2015 Guidance Read more about Supernus Announces Third Quarter 2015 Financial Results and Raises 2015 Guidance
Supernus Announces FDA Acceptance of sNDA to Add Migraine to Trokendi XR(R) Label Read more about Supernus Announces FDA Acceptance of sNDA to Add Migraine to Trokendi XR(R) Label
Supernus to Host Third Quarter 2015 Earnings Conference Call Read more about Supernus to Host Third Quarter 2015 Earnings Conference Call
Supernus Announces Settlement With Par on Trokendi XR(R) Patent Litigation Read more about Supernus Announces Settlement With Par on Trokendi XR(R) Patent Litigation
Supernus Announces Issuance of Fifth U.S. Patent Protecting Oxtellar XR® Read more about Supernus Announces Issuance of Fifth U.S. Patent Protecting Oxtellar XR®
Supernus to Attend FBR Healthcare Conference on September 9th Read more about Supernus to Attend FBR Healthcare Conference on September 9th
Supernus Announces Second Quarter 2015 Financial Results Read more about Supernus Announces Second Quarter 2015 Financial Results
Supernus to Host Second Quarter 2015 Earnings Conference Call Read more about Supernus to Host Second Quarter 2015 Earnings Conference Call
Supernus Corrects Earlier Statement Regarding Distribution of Common Stock by NEA Read more about Supernus Corrects Earlier Statement Regarding Distribution of Common Stock by NEA
Supernus Announces Distribution of Common Stock by NEA Read more about Supernus Announces Distribution of Common Stock by NEA